Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 3, 2005, Pages 312-316

  Gomez Lopez, Alicia ^a   Mellado, Emilia ^a   Rodriguez Tudela, Juan L ^a   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Fluconazole resistance; Ravuconazole; Rhodotorulla; Susceptibility of emerging yeasts

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FUNGAL STRAIN; HUMAN; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; REVIEW; RHODOTORULA; RHODOTORULA GLUTINIS;

ANTIFUNGAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; RHODOTORULA;

EID: 15844419911     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki020     Document Type: Review

References (24)

1. Kwon-Chung, K. J. & Bennett, J. E. (1992). Infections due to Trichosporon and other miscellaneous yeast-like fungi. In Medical Mycology (Kwon-Chung, K. J. & Bennett, J. E., Eds), pp. 768-82. Lea & Febiger, Malvern, PA, USA.
2. Walsh, T. J., Groll, A., Hiemenz, J. et al. (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clinical Microbiology and Infection 10, Suppl. 1, 48-66.
3. Braun, D. K. & Kauffman, C. A. (1992). Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses 35, 305-8.
4. Kiehn, T. E., Gorey, E., Brown, A. E. et al. (1992). Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clinical Infectious Diseases 14, 841-6.
5. Zaas, A. K., Boyce, M., Schell, W. et al. (2003). Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. Journal of Clinical Microbiology 41, 5233-5.
6. Anatoliotaki, M., Mantadakis, E., Galanakis, E. et al. (2003). Rhodotorula species fungemia: a threat to the immunocompromised host. Clinical Laboratory 49, 49-55.
7. Samonis, G., Anatoliotaki, M., Apostolakou, H. et al. (2001). Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection 29 173-6.
8. Marinova, I., Szabadosova, V., Brandeburova, O. et al. (1994). Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature. Chemotherapy 40, 287-9.
9. Kurtzman, C. P. & Fell, J. W. (1998). The Yeasts. A Taxonomic Study, 4th edn. Elsevier, Amsterdam, The Netherlands.
10. Rodriguez-Tudela, J. L., Barchiesi, F., Bille, J. et al. (2003). Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clinical Microbiology and Infection 9, i-viii.
11. National Committee for Clinical Laboratory Standards. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast - Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA.
12. Cuenca-Estrella, M., Lee-Yang, W., Ciblak, M. A. et al. (2002). Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrobial Agents and Chemotherapy 46, 3644-7.
13. Rodriguez-Tudela, J. L., Martin-Diez, F., Cuenca-Estrella, M. et al. (2000). Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrobial Agents and Chemotherapy 44, 400-4.
14. Espinel-Ingroff, A., Pfaller, M., Messer, S. A. et al. (1999). Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. Journal of Clinical Microbiology 37, 591-5.
15. Maxwell, M. J., Messer, S. A., Hollis, R. J. et al. (2003). Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. Journal of Clinical Microbiology 41, 1087-90.
16. Espinel-Ingroff, A. (1998). In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. Journal of Clinical Microbiology 36, 198-202.
17. Garcia-Martos, P., Dominguez, I., Marin, P. et al. (2001). Antifungal susceptibility of emerging yeast pathogens. Enfermedades Infecciosas y Microbiología Clinica 19, 249-56.
18. Hsueh, P. R., Teng, L. J., Ho, S. W. et al. (2003). Catheter-related sepsis due to Rhodotorula glutinis. Journal of Clinical Microbiology 41, 857-9.
19. Serena, C., Pastor, F. J., Ortoneda, M. et al. (2004). In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts. Antimicrobial Agents and Chemotherapy 48, 2724-6.
20. Carrillo-Muñoz, A. J., Quindos, G., Gasser, I. et al. (1999). Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system. Revista Española de Quimioterapia 12, 126-35.
21. Galan-Sanchez, F., Garcia-Martos, P., Rodriguez-Ramos, C. et al. (1999). Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples. Mycopathologia 145, 109-12.
22. Koc, A. N., Gokahmetoglu, S. & Oguzkaya, M. (2000). Comparison of Etest with the broth microdilution method in susceptibility testing of yeast isolates against four antifungals. Mycoses 43 293-7.
23. Preney, L., Theraud, M., Guiguen, C. et al. (2003). Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp. Mycoses 46, 492-5.
24. Cuenca-Estrella, M. & Rodriguez-Tudela, J. L. (2001). Present status of the detection of antifungal resistance: the perspective from both sides of the ocean. Clinical Microbiology and Infection 7 Suppl. 2, 46-53.